Tenaya Therapeutics Inc logo

TNYA

Materials

Tenaya Therapeutics Inc

$0.79+0.04 (+4.76%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving TNYA Today?

No stock-specific AI insight has been generated for TNYA yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$171M
P/E Ratio
EPS
Dividend Yield
Dividend / Share
ROE
Profit Margin
Debt / Equity

Trading

Volume4.9M
Avg Volume (10D)
Shares Outstanding217.0M

TNYA News

20 articles

All 20 articles loaded

Price Data

Open$0.75
Previous Close$0.75
Day High$0.82
Day Low$0.75
52 Week High
52 Week Low

About Tenaya Therapeutics Inc

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

70 employees
Listed July 30, 2021
MaterialsBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Company Details

Security TypeStock
ExchangeNASDAQ
Currency
Round Lot
SICBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CIK
Composite FIGI
Share Class FIGI